Mr. Pat O'Mahony:

I would add that the role then extends beyond approving the clinical trial to taking reports of any adverse outcomes during the clinical trial and to inspection of the clinical trial sites. We have inspectors who are trained in this area and we inspect sites on a cycle. When a trial is finished the close-out reports are made. Professor Crown is an expert in this area.